Genetic characterisation of drug resistance and clonal dynamics of Acinetobacter baumannii in a hospital setting in Mexico

International Journal of Antimicrobial Agents

Volumn 45, Issue 3, 2015, Pages 309-313

  Bocanegra Ibarias, Paola ^a   Peña López, Cynthia ^a   Camacho Ortiz, Adrian ^a   Llaca Díaz, Jorge ^a   Silva Sánchez, Jesús ^b   Barrios, Humberto ^b   Garza Ramos, Ulises ^b   Rodríguez Flores, Adrian Marcelo ^a   Garza González, Elvira ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Acinetobacter; Biofilm; Carbapenemases; OXA 58; OXA 72; PFGE

Indexed keywords

CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CRYSTAL VIOLET; IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BLAOXA 58 GENE; BLAOXA 72 GENE; BROTH DILUTION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; TERTIARY CARE CENTER; ACINETOBACTER INFECTIONS; AGED; BIOFILM; CLASSIFICATION; CROSS INFECTION; DRUG EFFECTS; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MOLECULAR TYPING; MORTALITY; PHYSIOLOGY; SURVIVAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BIOFILMS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOTYPE; HOSPITALS; HUMANS; MALE; MEXICO; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; SURVIVAL ANALYSIS;

EID: 84923686923     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.10.022     Document Type: Article

References (15)

1. N. Karah, A. Sundsfjord, K. Towner, and O. Samuelsen Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii Drug Resist Updat 15 2012 237 247
2. T.L. Chen, L.K. Siu, R.C. Wu, M.F. Shaio, L.Y. Huang, and C.P. Fung Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii Clin Microbiol Infect 13 2007 801 806
3. S. Mendoza-Olazarán, A. Camacho-Ortiz, M.F. Martínez-Reséndez, J.M. Llaca-Díaz, E. Péez-Rodríguez, and E. Garza-González Influence of whole-body washing of critically ill patients with chlorhexidine on Acinetobacter baumannii isolates Am J Infect Control 42 2014 874 878
4. S.G. Bartual, H. Seifert, C. Hippler, M.A. Luzon, H. Wisplinghoff, and F. Rodríguez-Valera Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii J Clin Microbiol 43 2005 4382 4390
5. A.P. Magiorakos, A. Srinivasan, R.B. Carey, Y. Carmeli, M.E. Falagas, and C.G. Giske Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Clin Microbiol Infect 18 2012 268 281
6. M.J. Ellington, J. Kistler, D.M. Livermore, and N. Woodford Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases J Antimicrob Chemother 59 2007 321 322
7. M. Baroud, I. Dandache, G.F. Araj, R. Wakim, S. Kanj, and Z. Kanafani Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases Int J Antimicrob Agents 41 2013 75 79
8. P. Nordmann, and L. Poirel Emerging carbapenemases in Gram-negative aerobes Clin Microbiol Infect 8 2002 321 331
9. N. Woodford, M.J. Ellington, J.M. Coelho, J.F. Turton, M.E. Ward, and S. Brown Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27 2006 351 353
10. M.E. Falagas, I.A. Bliziotis, and I.I. Siempos Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies Crit Care 10 2006 R48
11. A.C. Gales, M. Castanheira, R.N. Jones, and H.S. Sader Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010) Diagn Microbiol Infect Dis 73 2012 354 360
12. B. Heinemann, H. Wisplinghoff, M. Edmond, and H. Seifert Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains Antimicrob Agents Chemother 44 2000 2211 2213
13. H. Wisplinghoff, M. Decker, C. Haefs, O. Krut, G. Plum, and H. Seifert Mutations in gyrA and parC associated with resistance to fluoroquinolones in epidemiologically defined clinical strains of Acinetobacter baumannii J Antimicrob Chemother 51 2003 177 180
14. C.J. Sanchez Jr., K. Mende, M.L. Beckius, K.S. Akers, D.R. Romano, and J.C. Wenke Biofilm formation by clinical isolates and the implications in chronic infections BMC Infect Dis 13 2013 47
15. F. Minandri, S. D'Arezzo, L.C. Antunes, C. Pourcel, L. Principe, and N. Petrosillo Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter baumannii strains belonging to international clonal lineage II J Clin Microbiol 50 2012 590 597